Published by
Reuters UK
Reuters UK
FRANKFURT (Reuters) – Bayer shareholder Union Investment on Monday came out in support of the drugmaker’s chief executive serving out his full term after the CEO came under renewed pressure over the company’s performance. The support of Germany’s Union Investment, which is a top-20 shareholder, for CEO Werner Baumann to see out his contract to 2024 comes after Bloomberg reported over the weekend that Singapore state investor Temasek, another large shareholder, was pushing for Baumann’s removal. Bloomberg, which cited people familiar with the matter, said Temasek had concerns about Bayer’s oper…